ATE427744T1 - Verwendung einer fluchtigen, rhinologisch wirksamen zusammensetzung auf faserigen gewebe zur erleichterung der nasalen atmung - Google Patents

Verwendung einer fluchtigen, rhinologisch wirksamen zusammensetzung auf faserigen gewebe zur erleichterung der nasalen atmung

Info

Publication number
ATE427744T1
ATE427744T1 AT05004303T AT05004303T ATE427744T1 AT E427744 T1 ATE427744 T1 AT E427744T1 AT 05004303 T AT05004303 T AT 05004303T AT 05004303 T AT05004303 T AT 05004303T AT E427744 T1 ATE427744 T1 AT E427744T1
Authority
AT
Austria
Prior art keywords
volatile
active composition
nasal breathing
composition
skin
Prior art date
Application number
AT05004303T
Other languages
English (en)
Inventor
Joerg Kleinwaechter
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE427744T1 publication Critical patent/ATE427744T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Paper (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
AT05004303T 2005-02-28 2005-02-28 Verwendung einer fluchtigen, rhinologisch wirksamen zusammensetzung auf faserigen gewebe zur erleichterung der nasalen atmung ATE427744T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05004303A EP1698331B1 (de) 2005-02-28 2005-02-28 Verwendung einer flüchtigen, rhinologisch wirksamen Zusammensetzung auf faserigen Gewebe zur Erleichterung der nasalen Atmung

Publications (1)

Publication Number Publication Date
ATE427744T1 true ATE427744T1 (de) 2009-04-15

Family

ID=34933972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05004303T ATE427744T1 (de) 2005-02-28 2005-02-28 Verwendung einer fluchtigen, rhinologisch wirksamen zusammensetzung auf faserigen gewebe zur erleichterung der nasalen atmung

Country Status (7)

Country Link
EP (1) EP1698331B1 (de)
AT (1) ATE427744T1 (de)
AU (1) AU2005328317B2 (de)
CA (1) CA2599614C (de)
DE (1) DE602005013745D1 (de)
MX (1) MX2007010476A (de)
WO (1) WO2006093537A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196405A1 (en) * 2006-02-22 2007-08-23 The Procter & Gamble Company Fibrous structures comprising volatile agents
CA2923519A1 (en) 2007-08-10 2009-02-19 Little Busy Bodies, Llc Saline nose wipe and methods of manufacture and use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB672254A (en) * 1949-05-24 1952-05-21 Griffiths Hughes Ltd E Improvements in or relating to pocket inhalers
US3818533A (en) * 1969-07-18 1974-06-25 Alustikin Prod Inc Treated paper and non-woven material for wiping surfaces and method therefor
US5275859A (en) * 1992-12-21 1994-01-04 Eastman Kodak Company Tobacco smoke filter
US5607754A (en) * 1993-11-12 1997-03-04 Kimberly-Clark Corporation Paper web product and method for manufacturing same
US6238682B1 (en) * 1993-12-13 2001-05-29 The Procter & Gamble Company Anhydrous skin lotions having antimicrobial components for application to tissue paper products which mitigate the potential for skin irritation
US5830487A (en) * 1996-06-05 1998-11-03 The Procter & Gamble Company Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products
AU711717B2 (en) * 1994-12-19 1999-10-21 Procter & Gamble Company, The Medicated tissue paper product
AU724588B2 (en) * 1997-04-09 2000-09-28 Kao Corporation Skin cleansing sheet
US6602387B1 (en) * 1999-11-26 2003-08-05 The Procter & Gamble Company Thick and smooth multi-ply tissue
DE10058459A1 (de) * 2000-11-24 2002-06-06 Haarmann & Reimer Gmbh Rhinologica
JP4342761B2 (ja) * 2001-04-17 2009-10-14 花王株式会社 殺菌剤組成物
DE10246836A1 (de) * 2002-10-08 2004-04-22 Saxol Chemie Gmbh Wasserfreie oder wasserhaltige Zusammensetzung zur Behandlung eines hydrophilen Papierprodukts

Also Published As

Publication number Publication date
MX2007010476A (es) 2007-10-15
CA2599614A1 (en) 2006-09-08
WO2006093537A1 (en) 2006-09-08
AU2005328317B2 (en) 2009-09-10
CA2599614C (en) 2012-07-03
AU2005328317A1 (en) 2006-09-08
EP1698331A1 (de) 2006-09-06
EP1698331B1 (de) 2009-04-08
DE602005013745D1 (de) 2009-05-20

Similar Documents

Publication Publication Date Title
CL2008003363A1 (es) Uso de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina y sus sales farmaceuticamente aceptables para tratar depresion severa, ansiedad, abuso o dolor cronico, en pacientes que han recibido medicacion con anterioridad y que han abandonado o reducido a eventos adversos relacionados con el sueño o la actividad sexual.
WO2007061750A3 (en) Adipose tissue derived stromal cells for the treatment of neurological disorders
MXPA03006855A (es) Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion.
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
WO2008060610A3 (en) Systemic administration of colony stimulating factors to treat amyloid associated disorders
BR0207963A (pt) Produtos para cuidado da pele com maciez melhorada de pele e material
MX2009009417A (es) Piperidinil-piperidina y piperazinil-piperidina para uso en el tratamiento de diabetes o dolor.
TW200719882A (en) Treatment of connective tissue diseases of the skin
Oh et al. Effects of aroma gargling, cold water gargling, and wet gauze application on thirst, halitosis, and sore throat of patients after spine surgery
WO2003011327A3 (en) Secretin for the treatment of asthma
WO2006017566A3 (en) Modulation of bio-electrical rhythms via a novel engineering approach
CA2634419C (en) Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
AR059864A1 (es) Compuesto de benzamida composicion farmaceutica que lo comprende su uso para preparar un medicamento y procedimientos para su preparacion
PL2165704T3 (pl) Zastosowanie alweryny w leczeniu dolegliwości skórnych
ATE427744T1 (de) Verwendung einer fluchtigen, rhinologisch wirksamen zusammensetzung auf faserigen gewebe zur erleichterung der nasalen atmung
ITRM20050514A1 (it) Olio ozonizzato, principio attivo di elevata stabilita' a base di perossidi utilizzabile per applicazioni terapeutiche mediche e per trattamenti domiciliari similari a quelli dell'ozonoterapia, senza l'utilizzo di ozono gassoso.
FR2887766B1 (fr) Composition cosmetique comprenant des elastomeres
NZ597657A (en) Use sulphur particles less than 300 microns and sodium lignin sulfonate for treating diseases casused by microbial pathogenic infections
TN2010000249A1 (en) New medical use of 3-(2,2,2-trimethylhydrazinium ) propionate salts
DE60228988D1 (de) Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen
JP4689223B2 (ja) 家庭用衛生薄葉紙
BRPI0412923A (pt) composição farmacêutica dispersìvel para o tratamento de mastite e de distúrbios óticos
JP3252507U (ja) 二面薬物成分構造を有する人中穴用穴位貼付剤
CN201085732Y (zh) 麻醉手术用一次性眼部护贴
ATE435651T1 (de) Verwendung der cinchonapflanze zur herstellung eines medikamentes zur stimulierung der angiogenese

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties